CNTX
Context Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.620
High
$0.620
Low
$0.620
Volume
0.18M
Company Fundamentals
Trading Stats
Related News
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager Expect to share initial data in the first half of 2026 PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc.
Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer
PHILADELPHIA, May 29, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. ("Context" or "Company") (NASDAQ:CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid
Related Stocks
ENJ
Entergy New Orleans LLC First Mortgage Bonds 5.0% Series due December 1 2052
TRIN
Trinity Capital Inc.
PECO
Phillips Edison & Company Inc.
BSM
Black Stone Minerals L.P. Common units representing limited partner interests
CCCS
CCC Intelligent Solutions Holdings Inc.
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.